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Prostaglandm endoperoxlde synthase was subJected to the computer-asslsted homology search m the protein pnmary structure database, m order 
to mvestlgate the regulation mechanism of the expresslon of prostaglandm endoperoxlde synthase As a result of that, It turned out that prosta- 
glandm endoperoxlde synthase shares sequence homology with epldermal growth factor (EGF) m the N-termmal region The lmphcatlon of the 
existence of an EGF-hke domain m prostaglandm endoperoxlde synthase IS dlscussed 
Prostaglandm endoperoxlde synthase, Epldermal growth factor, Sequence homology 
1. INTRODUCTION 
The first step of the pathway for the conversion of 
arachidonic acid and related unsaturated fatty acids to 
the prostanoids is initiated by prostaglandin endoper- 
oxide synthase. The enzyme has two enzymatic ac- 
tivities, that is, a brs-oxygenase activity and a hydroper- 
oxidase activity [l-5]. The former initiates the forma- 
tion of the prostaglandin G and the latter is involved in 
the reduction of prostaglandm G to prostaglandin H. 
Recently, the primary structure of sheep prostaglandin 
endoperoxide synthase was determined and the homo- 
logies with heme proteins and the other peroxidases 
were reported [6-81. 
(release 19 0) [lo] The homology search system used m this study was 
described m [II] The detected homologous sequences were aligned 
and subJected to the statlsbcal test m order to check the slgmflcance 
of the slmllarlty [12] 
3. RESULTS AND DISCUSSION 
Thus, prostaglandin endoperoxide synthase occupies 
an important position in the metabolism of prostanoid 
and the regulation of prostaglandm endoperoxide syn- 
thase controls the rate of prostanoid synthesis. 
Therefore, the regulation mechanism of the prostaglan- 
din endoperoxide synthase has been studied extensively. 
One of the interesting observations is that EGF can af- 
fect the expression of the prostaglandin endoperoxide 
synthase [9]. 
As a result of the computer-assisted homology 
search, it turned out that the N-terminal region of the 
prostaglandin endoperoxide synthase is homologous 
with the entire region of epidermal growth factor 
(EGF). The detected homologous regions were aligned 
(see fig.1) and subjected to the statistical test. The 
degree of similarity between the prostaglandin endoper- 
oxide synthase and EGF is not so strong; however, the 
statistical test shows that those homologies between 
them are significant (see table 1). That is, the EGF-like 
domain of the prostaglandm endoperoxide synthase has 
an evolutionary relationship with EGF and the enzyme 
is considered to have appeared during the course of the 
evolution by exon-shuffling events [ 131. 
In order to investigate the relationship of the regula- 
tion mechanism of the prostaglandin endoperoxide syn- 
thase with the known organic regulation system, homo- 
logy search of the prostaglandin endoperoxide synthase 
in protein primary structure database was carried out. 
As a result of that, it turned out that the N-terminal 
region of the prostaglandin endoperoxide synthase 
shares significant sequence homology with EGF. 
2. EXPERIMENTAL 
Prostaglandm endoperoxlde synthase was subjected to the 
computer-asslsted homology search m the protein database, NBRF 
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There is a wide variety of proteins which contain 
EGF-like domains, for example, the products of neuro- 
gemc genes (Delta and Notch), coagulation factor pre- 
cursors (IX, X, XII, and VII), Lin12 homeotic protein, 
protein C, and protein Z, etc., although the roles of 
those EGF-like domains have remained unknown. 
These EGF-like domains are classified into 3 groups, 
type 1, type 2 and type 3, discriminated from each other 
by the length and the sequence between the conserved 
cysteine residues [141. The 6 conserved cysteine residues 
of the detected EGF-like domain have been numbered 
as Cys’-Cys6, following the order in which they appear 
m the alignment (see fig.1). Judging from the difference 
of the sequence and the length between Cys’ and Cys6, 
the EGF-like domain of prostaglandm endoperoxide 
synthase can be discriminated from the type 3 EGF-hke 
sequence. The similarity of the sequence and the other 
characters (data not shown) suggest hat the detected 
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(a) PVNPCC---YYP-CPHQGICVRF-GLDRY~~DCTRTGYSGPNCTIPS~-WTW-LR 
(b) NSYPGCPSSYDGYCLNCCVCMHTESLDSYTCNCV-~GYSGDRC~TRDLRW-WELR 
(c) NSNTGCPPSYDGYCLNCCVCMYVESVDRYVCNCV-lGYIGERCQHRDLR------ 
(d) NSDSECPLSHDGYCLHDGVCMYIEbLDKYACNCV-VGYlGERCQYRDLKW-WELR 
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Fig 1 Ahgnment of the N-terminal region of the prostaglandm endo- 
peroxlde synthase and the epldermal growth factors from different 
sources 0 indicates the site occupied by an ldentlcal ammo acid and 
0 Indicates the site occupred by a similar ammo acid group [12] 
Gaps (-_) were introduced to align the regions which have been sub- 
jected to the msertlon/deletlon events (a) The ammo acid sequence 
from the prostaglandm endoperoxlde synthase (residue positions 
8-55, see [6]). (b) The ammo acid sequence of mouse EGF (residue 
positions 977-1029, see 1201) (c) The ammo acid sequence of rat EGF 
(residue posItions l-48, see [21]) (d) The ammo acid sequence of the 
human EGF (residue posltlons l-53, see [22]) 
EGF-like domain is related to type 1 and type 2 EGF- 
like sequences. However, the length between Cys3 and 
Cys4 of the detected EGF-like domain is a little dif- 
ferent from those of type 1 and type 2 EGF-like se- 
quences. Therefore, the purpose of the detected EGF- 
like domain has not been identified. 
It was reported that prostaglandin endoperoxide syn- 
thase is homologous with the other peroxidases and the 
homology was also detected by our homology search. A 
region of prostaglandin endoperoxrde synthase, residue 
positions 198-330 [6], is homologous with a region of 
thyroperoxidase, residue positions 318-459 [15], and a 
region of myeloperoxrdase, residue positions 331-468 
[16]. However, the structure of these peroxidases are 
different from each other. Prostaglandin endoperoxide 
synthase has the following conformation: N-terminal- 
EGF-like domain-(transmembrane region whrch has 
not been identified yet)-the region shared by the 3 per- 
oxidases. Contrary to that, myeloperoxidase has the 
following conformation: N-terminal-the region shared 
by 3 peroxidases-cytochrome c oxidase-like domain-C- 
terminal. Thyroperoxidase has a conformation similar 
to that of myeloperoxidase, although it contains a C- 
Table 1 
The results of the statIstica test - identities of each aligned pour 
PES EGF EGF EGF 
(sheep) (mouse) (rat) (human) 
PES (sheep) - 655SD 417SD 56OSD 
EGF (mouse) 37 7% - 12 24 S D 1306SD 
EGF (rat) 32 6% 77 1% 12 25 S D 
EGF (human) 34 0% 69 8qo 68 8% 
The normahzed devlatlons of the alignment scores from the mean 
value of the scores for the randomized sequences (the upper half of 
the table) and the Identity (To) of the aligned sequence (the lower half 
of the table). PES = prostaglandm endoperoxlde synthase and EGF 
= epldermal growth factor The names m the parentheses indicate the 
source animals of the protems The alignment used m this calculation 
is shown m fig 1 The score matrix MDM7s was used for the statistical 
test [12] The contmuous gaps were treated as single substitutions 
regardless of their length and a score of - 60 was assigned to the gaps 
WI 
318 
terminal extension: N-terminal-the region shared by 
3 peroxidases-cytochrome c oxidase-like domain- 
C46-like domain - EGF-like domain-transmem- 
brane-C-terminal. It is an interesting observation that 
thyroperoxidase also contains an EGF-like domain, 
although the position of the EGF-hke domain in 
thyroperoxidase is different from that in prostaglandin 
endoperoxide synthase and the EGF-like domain of 
thyroperoxidase belongs to the type 3 EGF-like se- 
quence. Therefore, it is considered that the fusions of 
EGF-like domain and peroxidase found in prostaglan- 
din endoperoxide synthase and thyroperoxidase are 
considered to have occurred independently during the 
course of their evolution. 
The cysteine residues found m EGF bind with each 
other by disulfide bonds. As shown in fig. 1, all the cys- 
teine residues corresponding with those of EGF are con- 
served in the EGF-like domain of prostaglandin endo- 
peroxide synthase. Therefore, rt is strongly suggested 
that these cysteine residues in the EGF-like domain may 
also bind with each other by disulfide bonds. The N- 
terminal region of the prostaglandin endoperoxide syn- 
thase is considered to be one of the luminal domains 
from the hydropathy profile and the pattern of the 
distribution of putative glycosylation sites [5-71. The 
existence of the cysteine residues which may participate 
in forming disulfide bonds also supports this 
hypothesis. One of the putative glycosylation sites is 
found in the detected EGF-like domain (Asn residue of 
alignment positron 42; see fig.1). 
On the other hand, there are several ines of evidence 
that EGF can affect the biosynthesis of prostaglandin 
[ 17-191. Particularly, one interesting observation is the 
recovery of the activity of the prostaglandin endoperox- 
rde synthase by EGF and TGF-fi after inhibition by 
aspirin [9]. The experiments howed that the stimula- 
tion by EGF and TGF-fi produces the increase of 
mRNA of the prostaglandin endoperoxide synthase, al- 
though the details of the mechanism for the control of 
the expression of prostaglandin endoperoxide synthase 
by these growth factors has remained unknown. From 
the existence of the EGF-like domain, together with the 
experimental observations described above, we specu- 
late that the prostaglandin endoperoxide synthase may 
regulate the expression of itself by positive or negative 
feedback mechanism, using the EGF-like domain. 
The structural and functional implications of the 
EGF-like domain detected by computational analysis 
should be investigated by experimental work. 
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